We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Weak to moderate cytoplasmic immunoreactivity was observed in most malignant cells. Additional membranous positivity was displayed by colorectal and endometrial cancers. A few cases of colorectal, breast, urothelial,
gastric and occasional pancreatic cancers were strongly stained.
GENE INFORMATION
Gene name
CREBL2
Synonyms
Description
CAMP responsive element binding protein-like 2 (HGNC Symbol)
Entrez gene summary
cAMP response element (CRE)-binding protein-like-2 (CREBL2) was identified in a search to find genes in a commonly deleted region on chromosome 12p13 flanked by ETV6 and CDKN1B genes, frequently associated with hematopoietic malignancies, as well as breast, non-small-cell lung and ovarian cancers. CREBL2 shares a 41% identity with CRE-binding protein (CREB) over a 48-base long region which encodes the bZip domain of CREB. The bZip domain consists of about 30 amino acids rich in basic residues involved in DNA binding, followed by a leucine zipper motif involved in protein dimerization. This suggests that CREBL2 encodes a protein with DNA binding capabilities. The occurance of CREBL2 deletion in malignancy suggests that CREBL2 may act as a tumor suppressor gene. [provided by RefSeq, Jul 2008]